Financial Data and Key Metrics Changes - The company reported net sales of $660 million for the first quarter of 2025, representing a 3% increase compared to the same period last year [6] - Adjusted EBITDA was $67 million, with an adjusted EBITDA margin of 10.2%, which is 220 basis points lower than the same period last year [8][30] - Free cash flow was negative $41 million, a decline from positive $12 million in the same period last year [9][33] - Net income decreased to $13.3 million from $37.5 million year-over-year, primarily due to higher selling, general, and administrative expenses [28] Business Line Data and Key Metrics Changes - The Supreme acquisition contributed to a 10% growth, while legacy business saw a 2% increase in net average selling prices (ASP) [7] - Market volume declines of 9% were noted in the base business, particularly affecting customers in the repair and remodel market [7] - Builder Direct sales increased by over 4% compared to the prior year, despite declines in the new construction market [8] Market Data and Key Metrics Changes - Year-over-year market volume declines were observed across all channels and end markets in the first quarter [10] - The new construction market is expected to decline by mid-single digits for the full year 2025, influenced by lower foot traffic and builder commentary [12] - The repair and remodel market is anticipated to decline by high to mid-single digits for 2025, with fluctuations in order patterns noted [14][16] Company Strategy and Development Direction - The company is focusing on cost preservation and maintaining a strong balance sheet while investing in targeted growth areas [17] - Facility consolidations are underway to reduce costs and improve service, with expected financial benefits materializing in the third quarter [19] - Strategic initiatives include "Align to Grow," "Lead through Lean," and "Tech Enabled," aimed at positioning the company for future growth [20][25] Management's Comments on Operating Environment and Future Outlook - Management noted that the current demand environment is choppy, with expectations of continued weakness in the second half of 2025 [10][12] - Tariffs are impacting consumer confidence and large ticket purchases, contributing to a more cautious outlook for the year [16][39] - The company anticipates adjusted EBITDA for 2025 to be in the range of $315 million to $365 million, with a focus on balancing near-term performance and long-term growth [41][42] Other Important Information - The company ended the quarter with $113.5 million in cash and $358.6 million in liquidity available [30] - A new share repurchase program was authorized, allowing for the repurchase of up to $50 million of common stock [33] Q&A Session Summary Question: How is the company thinking about pricing in relation to tariffs? - Management indicated that additional pricing actions are necessary to counteract tariff impacts, using a surcharge methodology [46][48] Question: What is the expected demand cadence for Q2? - Management expects to see normal seasonality in Q2, but acknowledges challenges due to tariff costs and inefficiencies in certain factories [53][66] Question: How will margin progression look in Q2? - Margins are expected to improve from Q1, but not to the company's standards due to fixed cost pressures and tariff impacts [64][66] Question: What factors will influence the EBITDA guidance range? - The range is primarily dictated by market demand and the company's ability to gain market share amidst tariff uncertainties [69][70] Question: How does the company view its position relative to tariffs? - The company believes it is better insulated from tariffs due to its production being predominantly in the U.S., allowing it to absorb volume changes more effectively [75][78]

Financial Data and Key Metrics Changes - The company reported net sales of $660 million for the first quarter of 2025, representing a 3% increase compared to the same period last year [6][24] - Adjusted EBITDA was $67 million, with an adjusted EBITDA margin of 10.2%, which is 220 basis points lower than the same period last year [7][28] - Net income decreased to $13.3 million from $37.5 million year-over-year, primarily due to higher selling, general, and administrative expenses [26][30] - Free cash flow was negative $41 million, compared to positive $12 million in the same period last year [9][30] Business Line Data and Key Metrics Changes - The Supreme acquisition contributed to a 10% growth, while the legacy business saw a 2% increase in net average selling prices (ASP) [6][7] - Builder Direct sales increased by over 4% year-over-year, despite declines in the new construction market [7] - The repair and remodel market experienced mid-single-digit declines, particularly in lower-priced products [13][14] Market Data and Key Metrics Changes - Year-over-year market volume declines were observed across all channels and end markets, with the new construction market down low single digits [10][12] - The Canadian market saw high single-digit declines in both new construction and repair and remodel markets [15] - Overall end market demand is now expected to decline by high to mid-single digits in 2025, revised from previous expectations [16] Company Strategy and Development Direction - The company is focusing on cost preservation and maintaining a strong balance sheet while investing in targeted growth areas [16][19] - Facility consolidations are underway to improve efficiency and reduce costs, with expected benefits materializing in the third quarter [17][18] - Strategic initiatives include Align to Grow, Lead through Lean, and Tech Enabled, aimed at positioning the company for future growth [19][20][22] Management's Comments on Operating Environment and Future Outlook - Management noted that the current demand environment is choppy, with expectations for continued weakness in the second half of 2025 [10][12] - Tariffs are impacting consumer confidence and purchasing behavior, leading to a cautious outlook for large-ticket items [15][36] - The company anticipates adjusted EBITDA for 2025 to be in the range of $315 million to $365 million, with a wider range due to tariff uncertainties [38] Other Important Information - The company authorized a new share repurchase program of up to $50 million [30] - Capital expenditures for 2025 are expected to be between $75 million and $85 million, down from previous estimates [39] Q&A Session Summary Question: Thoughts on pricing and demand impacts - Management indicated that additional pricing actions are needed to counteract tariff impacts, with a focus on timing and customer negotiations [43][44] Question: Demand cadence and seasonality - Management expects a normal seasonal pattern in Q2, but acknowledges challenges due to tariffs and operational adjustments [49][50] Question: Margin progression in Q2 - Margins are expected to improve from Q1, but not to desired levels due to inefficiencies and tariff costs [58][61] Question: Factors affecting EBITDA guidance - The wide range in EBITDA guidance is primarily driven by market demand and the company's ability to gain market share [63][65] Question: Positioning relative to tariffs - The company is better insulated from tariffs due to its U.S.-based production, allowing it to absorb volume changes if necessary [70][72] Question: ASP trends and inventory growth - Management noted that inventory growth is partly due to safety stock and not a significant pre-buy, with plans to adjust inventory levels as demand stabilizes [78]

Financial Data and Key Metrics Changes - Total revenue for Q2 2025 was $1,005 million, a decrease of 0.5% in constant currency, but at the upper end of guidance [5][6] - Non-GAAP earnings per share were $1.30, flat compared to the previous year, reflecting solid gross margin expansion and benefits from share buybacks [6][30] - Operating cash flow generated in Q2 was $169.5 million, with cash and equivalents at $1,430 million at quarter end [10][34] Business Line Data and Key Metrics Changes - Diagnostics revenue was $453.6 million, growing 1.5% or 5.2% excluding COVID-related sales, driven by molecular diagnostics [14][17] - Breast Health revenue declined 6.9% to $356.2 million, with a 9.2% organic decline, attributed to lower gantry placements [18][39] - Surgical revenue increased 5.1% to $162.5 million, with international surgical business growing 16.2% [21][22] - Skeletal revenue grew 22.9% to $33 million, benefiting from improved production ramp of the DEXA system [23] Market Data and Key Metrics Changes - The company lowered sales expectations for China due to geopolitical turbulence, now forecasting only about $50 million in revenue from China for fiscal 2025 [12][36] - The diagnostics business in Africa faced declines due to funding cuts, impacting overall growth [17][55] Company Strategy and Development Direction - The company aims to accelerate growth in Breast Health and has reorganized its sales team to improve performance [19][20] - Hologic is actively seeking acquisitions and investments, with a focus on tuck-in M&A and returning value to shareholders through stock repurchases [11][33] - The company is confident in its strong market positions in core US and European markets, despite challenges in other regions [12][41] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver solid financial results despite macroeconomic challenges [5][6] - The company anticipates faster growth beginning in Q4 2025, driven by better commercial execution and new product introductions [12][36] - Management highlighted the importance of employee engagement and its role in navigating dynamic environments [10] Other Important Information - The company expects a gross impact of $20 to $25 million per quarter from recently announced tariffs, primarily affecting manufacturing in Costa Rica and China [26][27] - Non-GAAP gross margin improved to 61.1%, driven by strong diagnostics sales and the addition of EndoMag and Gynasonics [30] Q&A Session Summary Question: Impact of tariffs and supplier pricing - Management indicated that while there are potential higher costs from suppliers, they believe offsets will balance the impact [45][46] Question: Breast Health sales force reorganization - The reorganization aims to improve focus on capital and disposable product sales, with expectations of a more stable business moving forward [47][49] Question: Revenue guidance and Africa diagnostics weakness - The decline in revenue guidance is primarily due to reduced expectations from China and the impact of funding cuts in Africa [54][55] Question: Gantry replacement cycle - The average life of gantries has extended, and the company is in a replacement cycle, expecting steady placements moving forward [75][76] Question: Supply chain management - Management feels confident in their supply chain, with most manufacturing done in the US, and is evaluating options but not planning significant changes [69][71] Question: Molecular diagnostics contracting cycles - The molecular diagnostics business is expected to grow, despite headwinds from HIV testing declines in Africa [81][83]

Financial Data and Key Metrics Changes - Total revenue for Q2 2025 was $1,005 million, a decrease of 0.5% in constant currency, but at the upper end of guidance [7][8] - Non-GAAP earnings per share were $1.30, flat compared to the previous year, reflecting solid gross margin expansion and benefits from share buybacks [8][30] - Non-GAAP gross margin improved to 61.1%, up 40 basis points year-over-year [31][34] Business Line Data and Key Metrics Changes - Diagnostics revenue was $453.6 million, growing 1.5% or 5.2% excluding COVID-related sales, driven by molecular diagnostics [16][18] - Breast Health revenue declined 6.9% to $356.2 million, with a 9.2% decline organically, attributed to lower gantry placements [19][40] - Surgical revenue increased 5.1% to $162.5 million, with international surgical business growing 16.2% [23][24] - Skeletal revenue grew 22.9% to $33 million, exceeding internal expectations due to improved production [25] Market Data and Key Metrics Changes - The diagnostics division's growth was impacted by reduced HIV testing in Africa due to funding cuts, affecting overall performance [18] - Sales expectations for China were lowered due to geopolitical challenges, with anticipated revenue now at approximately $50 million for the fiscal year [14][66] Company Strategy and Development Direction - The company aims to accelerate growth in Breast Health and has reorganized its sales team to improve focus on capital and disposable product sales [20][21] - Strategic acquisitions, such as Endomagnetics and Gynasonics, are expected to enhance market position and drive future growth [13][35] - The company is exploring various mitigation strategies for tariff impacts, primarily from Costa Rica and China [27][29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate the challenging macroeconomic environment and anticipates improved growth rates in the fourth quarter [14][43] - The company expects to return to healthy growth in Breast Health by Q4 2025, driven by better commercial execution and new product introductions [40][43] Other Important Information - The company generated $169.5 million in operating cash flow in Q2 and ended the quarter with over $1.6 billion in cash and investments [12][35] - The effective tax rate for Q2 was 19%, reflecting adjustments to align with the expected full-year rate [34] Q&A Session Summary Question: Can you discuss the potential higher costs from suppliers and mitigation efforts? - Management indicated that while there are discussions about potential price increases, they believe they can offset these costs through their existing operations in Costa Rica [46][47] Question: What is the current appetite for capital from hospitals? - Management noted that the breast health business has stabilized, and they expect hospitals to allocate budgets for meaningful product improvements [48][75] Question: How is the company addressing the decline in Africa and China? - The company is de-risking its revenue expectations from China and addressing funding cuts affecting testing in Africa [14][66] Question: What is the outlook for the Breast Health business? - Management is optimistic about returning to steady growth in Breast Health, with improvements expected in the fourth quarter [40][54] Question: Can you provide insights on the gantry replacement cycle? - The average life of gantries has extended to 10-12 years, and the company is actively managing an end-of-life strategy for older units [78] Question: How is the company managing supply chain challenges? - Management expressed confidence in their supply chain, particularly for US-manufactured products, while evaluating potential adjustments as needed [73][74]

Financial Data and Key Metrics Changes - Consolidated revenue grew 1% on a reported basis and 3% on an organic constant currency basis [11] - Adjusted EBITDA declined by $3,500,000 year over year, impacted by a $2,600,000 impairment charge and $1,100,000 in preproduction startup costs [13][14] - Gross profit would have increased modestly if not for the impairment charge and startup costs [14] Business Line Data and Key Metrics Changes - Vista experienced 3% organic constant currency growth, with key growth categories like promotional products, signage, packaging, and labels growing at double-digit rates [11][12] - Consumer products returned to 5% growth after a decline in the previous quarter [12] - The business cards and stationary product category declined 3% year over year, showing slight improvement from a 4% decline in the previous quarter [12] Market Data and Key Metrics Changes - Strong performance in Europe despite macro headwinds, while the US market faced challenges due to organic search algorithm changes [12] - The promotional products and apparel category, which represents over 20% of consolidated revenue, is most exposed to tariff impacts [21][22] Company Strategy and Development Direction - The company is focused on expanding into elevated products to serve higher lifetime value customers and increase market share [5][10] - Plans to balance capital deployment between organic growth investments, reducing leverage, and share repurchases [20] - The company aims to navigate tariff challenges by identifying alternative sourcing and implementing price increases where applicable [18][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in delivering attractive growth in per share cash flow despite a noisy backdrop [4] - The company has withdrawn guidance for FY 2025 and beyond due to tariff uncertainty and potential impacts on demand [19][83] - Management believes that the current economic environment may lead to increased self-employment and demand for their products [46] Other Important Information - The company is investing in new production facilities and capabilities, particularly in the US [6][70] - The company is maintaining a high bar for growth investments while being cost-conscious in the current environment [41][74] Q&A Session Summary Question: Which customer verticals are most exposed to tariff impacts? - Management indicated that promotional products, apparel, and gifts are the most exposed, with PPAG representing over 20% of consolidated revenue [21][22] Question: What is the expected tariff expense on remaining China COGS? - The estimated tariff expense on the remaining $20,000,000 of China COGS is about $30,000,000, but pricing changes may offset some of this impact [27][29] Question: How is the company addressing potential demand drops due to tariffs? - Management stated they would reduce costs as needed and have constraints in place to manage operating expenses [40][41] Question: Can you provide an update on revenue growth in April? - Management noted that April's revenue trends were stable compared to March, complicated by holiday timing shifts [43][44] Question: What is driving the low growth at National Penn? - The low growth is attributed to reduced mail order advertising and stronger performance in e-commerce and cross fulfillment channels [45] Question: How does management view the long-term gross margin profile? - Management focuses on gross profit rather than gross margin percentages, emphasizing the importance of delivering value to customers [56][57] Question: What are the plans for capital allocation regarding share buybacks versus investments? - Management is actively considering trade-offs between share repurchases and internal investments, with a bias towards high-return growth investments [76][80]

Financial Data and Key Metrics Changes - Revenue in Q1 2025 declined by 4% compared to the same period last year, primarily due to weaker capital shipments in the Industrial Processing segment [11][18] - Adjusted EBITDA decreased by 8% to $48 million, with an adjusted EBITDA margin decline of 100 basis points compared to the prior year [11][20] - Free cash flow increased by 15% to $19 million in Q1 2025 compared to $16.6 million in Q1 2024 [21] Performance by Business Segment - **Flow Control Segment**: Bookings increased by 6% to $100 million, with Q1 revenue up 7% to $92 million, driven by strong demand for aftermarket parts [12][13] - **Industrial Processing Segment**: Q1 revenue declined by 15% to $90 million, largely due to a significant drop in capital shipments, although aftermarket parts revenue made up a record 80% of total revenue in this segment [14][15] - **Material Handling Segment**: Revenue was slightly up to $57 million, with aftermarket parts comprising 65% of Q1 revenue, despite a decline in capital equipment demand [15][16] Market Data and Key Metrics Changes - Aftermarket parts bookings represented 74% of total bookings, reaching a record $190 million in Q1 2025 [11] - The company noted that the geopolitical climate and trade policy uncertainties have introduced transitory headwinds, particularly affecting capital project timing [12][16] Company Strategy and Industry Competition - The company is exploring alternative supply sources to mitigate the impact of tariffs and is well-positioned to respond to changes in trade policy [6][7] - Management emphasized the importance of maintaining high levels of customer support while navigating the challenges posed by tariffs and geopolitical uncertainties [7][17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver value despite ongoing uncertainties, highlighting strong fundamentals in the markets served [16][17] - The company anticipates that the second half of 2025 will be significantly stronger than the first half, with expectations for improved capital order activity [30][31] Other Important Information - The effective tax rate for Q1 was 24.3%, influenced by tax benefits related to equity awards [20] - The company revised its full-year 2025 revenue guidance to $1.02 billion to $1.04 billion, down from previous estimates due to tariff impacts and delays in capital orders [29][30] Q&A Session Summary Question: What is the outlook for deferred orders and project activity? - Management indicated that while there is a pause in project activity due to tariffs, discussions and quote activity remain strong, with no significant project cancellations observed [36][40] Question: How does the company view the impact of tariffs on capital projects? - Management noted that while tariffs have caused delays, they do not expect a significant number of projects to be canceled, emphasizing the need for customers to eventually invest in new equipment [52][56] Question: What is the expected mix of parts versus capital sales for the year? - The company anticipates a parts and consumables revenue percentage of around 69% for the year, with expectations for improved capital revenues in the second half [67][69]

Financial Data and Key Metrics Changes - In Q1 2025, net sales increased by $19 million or 17% year-over-year to $131 million, driven by a 25% growth in Vita Coco coconut water net sales [23][26] - Gross profit for the quarter was $48 million, an increase of $1 million compared to the prior year, with gross margins at 37%, down approximately 550 basis points from 42% in Q1 2024 [25][26] - Net income attributable to shareholders was $19 million or $0.31 per diluted share, compared to $14 million or $0.24 per diluted share in the prior year [26] Business Line Data and Key Metrics Changes - Vita Coco coconut water net sales increased by 25%, while private label sales decreased by 12%, with private label coconut water growth of 10% offset by a decline in coconut oil [23][26] - The International segment saw net sales up 17%, with Vita Coco coconut water growing 36% across major markets [25] Market Data and Key Metrics Changes - Coconut water category growth was reported at 23% in the US and 19% in the UK for Q1 2025 [8] - Vita Coco coconut water grew 20% in retail dollars in the US and 21% in the UK [10] Company Strategy and Development Direction - The company aims to grow the Vita Coco brand by expanding the coconut water category and innovating around core offerings [7] - International growth is a priority, particularly in underdeveloped markets like Germany, which saw a doubling of volume sold compared to the same quarter last year [7][13] - The company is exploring innovation in adjacent categories and potential M&A opportunities to enhance shareholder value [8] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about branded coconut water growth in 2025, supported by a stronger inventory position and retail programming [10][14] - The company anticipates that international operations will eventually match the size of its American business [14] - Management is confident in navigating the current environment, including potential tariff impacts, due to a diversified sourcing strategy [21][22] Other Important Information - The company has a strong balance sheet with total cash of $154 million and no debt [28] - Share repurchase program has been increased to $65 million, with $23 million already utilized [28] Q&A Session Summary Question: Guidance for the year and mitigation efforts regarding tariffs - Management confirmed that the guidance includes the 10% baseline tariff and discussed ongoing cost-saving initiatives and potential pricing adjustments to offset tariff impacts [36][39] Question: SG&A growth guidance - The slight increase in SG&A growth guidance reflects a broader range due to uncertainty, with investments focused on marketing and team expansion [42][45] Question: Supply availability for growth - Management indicated that while coconut supply is abundant, planning and timing are critical for scaling operations [56][57] Question: Pricing strategy amidst growth - The company plans to take pricing in response to cost increases, balancing the need to maintain brand momentum [58][59] Question: Drivers of higher finished goods costs - Higher finished goods costs are attributed to new factory setups and elevated ocean freight rates compared to the previous year [62][67] Question: Shelf space and distribution strategy - The company expects improved shelf space and distribution gains, particularly in convenience stores and through successful product launches [114][116]

Financial Data and Key Metrics Changes - Sysco reported sales of $19.6 billion, an increase of 1.1% on a reported basis and 1.8% excluding the divestiture of Mexico [9][34] - Adjusted operating income was $773 million, down 3.3% year-over-year, while adjusted EPS remained flat at $0.96 [9][34] - Gross profit was $3.6 billion, down 0.8%, with a gross margin of 18.3% [37][41] Business Line Data and Key Metrics Changes - The USFS national sales business experienced flat volume growth and 2.3% sales growth, both below expectations [11] - Local business volume declined by 3.5%, a step down from Q2 performance [11] - The Sigma segment achieved 9.5% sales growth, driven by strong customer wins [12] Market Data and Key Metrics Changes - Foot traffic to restaurants decreased by 3.1% overall, with January down 1.3%, February down 5.7%, and March down 2.3% [5] - The International segment posted double-digit profit growth for the sixth consecutive quarter, with local volume increasing by 4.5% [22][36] Company Strategy and Development Direction - Sysco is focused on improving local business performance through hiring and retention of sales consultants, with a target of 4% growth in headcount by the end of Q4 [56][64] - The company is expanding fulfillment capacity with new facilities in key markets, including a new distribution center in Tampa [19][31] - A pilot program for cash and carry stores, called Sysco To Go, is being introduced to capture the growing market segment [29][31] Management's Comments on Operating Environment and Future Outlook - Management expressed disappointment with Q3 performance due to adverse weather and declining consumer confidence, but noted stronger performance in April compared to March [7][9] - The company is cautiously optimistic about Q4, expecting improved volume performance and continued momentum from cost-saving initiatives [46][51] - Management highlighted the importance of maintaining a strong balance sheet to navigate uncertain macroeconomic conditions [28][42] Other Important Information - Sysco's tariff management task force is actively working to mitigate the impact of tariffs on costs and supply chain [25][27] - The company has repurchased $700 million in shares and paid out $752 million in dividends year-to-date, with a 6% increase in the quarterly cash dividend [33][34] Q&A Session Summary Question: Local business sales headcount investments and their impact - Sysco expects to end the year with approximately 4% growth in sales consultant headcount, with strong performance from new hiring cohorts [56][58] Question: Local restaurant industry performance compared to national - National restaurants faced a tough quarter, with local performance consistent with industry trends, but certain sectors like food service management remained stable [68][70] Question: Clarification on local case growth and EPS guidance - Sysco's local case growth was consistent with market performance, and the company is confident in its guidance despite recent challenges [79][81]

Financial Data and Key Metrics Changes - Ampco-Pittsburgh Corporation reported earnings per common share of $0.16 for Q4 2024 and $0.02 for the full year [7] - Net cash flow from operating activities was $7.5 million for Q4 and $18 million for 2024 [8] - Consolidated net sales for Q4 2024 were $100.9 million, a decline of 6.6% compared to Q4 2023 [28] - Net income attributable to Ampco-Pittsburgh for Q4 2024 was $3.1 million, compared to a net loss of $41.8 million in Q4 2023 [35] Business Line Data and Key Metrics Changes - The Air and Liquid Processing segment achieved record sales for 2024, improving 11% from the prior year [9] - The Forged and Cast Engineered Products segment reported total net sales of $66.5 million in Q4 2024, down from $75.8 million in Q4 2023 [20] - Operating income for the Forged and Cast Engineered Products segment reached $10.5 million for the full year 2024, up from $7.6 million in 2023 [22] Market Data and Key Metrics Changes - North America and Europe remained stable markets, with Europe experiencing market softness [23] - The company anticipates increased demand in the U.S. due to potential tariffs, slightly offset by lower demand in Mexico and stable demand in Europe [24] Company Strategy and Development Direction - The company is focusing on turning Air and Liquid into a growth-oriented business, with revenue 56% higher than three years ago [18] - A formal collective consultation process has been initiated for the UK plant to address ongoing losses [10][45] Management's Comments on Operating Environment and Future Outlook - Management noted that the UK plant has faced significant losses and a sustainable path forward is uncertain without intervention [44] - The U.S. Navy's expansion plans and activity in the nuclear market are expected to drive future growth opportunities [51] Other Important Information - The total backlog at December 31, 2024, was $378.9 million, flat compared to December 31, 2023 [36] - Capital expenditures for full-year 2024 were $12.2 million, including final capitalization of the U.S. Forged plant modernization [38] Q&A Session Summary Question: Clarification on the UK situation and potential plant closure - Management indicated that significant losses have occurred in the UK, and without intervention, a sustainable path forward is not visible. The collective consultation process may lead to various outcomes, including potential closure [44][46] Question: Potential for market expansion in the air and liquid division - Management noted that there is increased activity in current markets, particularly with the U.S. Navy and nuclear sector, and opportunities for expansion beyond North America [51] Question: Debt levels and future CapEx plans - Management stated that debt levels are flat year-over-year, and future CapEx is expected to remain stable, supported by government grants [52][94] Question: Year-end backlog by business segment - The total backlog was reported as flat at $379 million, with $250.5 million in Forged and Cast Engineered Products and $128.4 million in Air and Liquid Processing [68] Question: Asbestos-related revaluations frequency - Management indicated that asbestos-related revaluations will likely be conducted annually moving forward to stay on top of changes [70]